Afferent Pharmaceuticals
San Mateo
About Afferent Pharmaceuticals
Afferent Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It develops medicines to treat chronic pain by targeting P2X3 receptors in nerve fibers. The company’s AF-219, a compound that completed two Phase 1 clinical studies. Afferent Pharmaceuticals, Inc. was founded in 2009 and is based in San Mateo, California.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $83.2M
- Funding stage: M&A
- Last round: Series C (Jul 2015)
- Website: afferentpharma.com
- Phone: (650) 286-1276
Industries & Categories
Biopharma, Biotechnology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/afferent-pharmaceuticals-2724802 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.